Gapping up
In reaction to strong earnings/guidance:
- FOLD +6.7%, JD +4.3%, EVRG +3%, HRTX +0.8%, XRAY +0.7%
M&A news:
- FTSV +62% (Gilead (GILD) to acquire Forty Seven for $99.50/share in cash)
- MINI +1.3% (WillScot (WSC) and Mobile Mini (MINI) to merge to form combined company with enterprise value of $6.6 bln); GILD +0.9%
Select metals/mining stocks trading higher:
- GDX +2.8%, GOLD +2.6%, PAAS +2.2%, GFI +1.9%, NEM +1.4%, GLD +1.3%, SLV +0.9%, .
Other news:
- APDN +58.4% (updates on COVID-19 collaboration with Takis Biotech, 4 Preclinical LinearDNA vaccine candidates designed)
- CODX +51.2% (following report about recent change to FDA's policy towards coronavirus outbreak)
- KPTI +43.8% (announces top-line results from the randomized Phase 3 BOSTON study evaluating once-weekly XPOVIO in combination with once-weekly Velcade)
- RFP +3.4% (authorizes $100 mln share repurchase)
- MRKR +3.2% (enters $30 mln Common Stock Purchase Agreement with Aspire Capital)
- STL +2.5% (authorizes repurchase of up to an additional 20.0 mln common shares)
- EYPT +2.3% (announced positive topline 36-month follow-up data from the second Phase 3 trial of YUTIQ 0.18 mg three-year micro-insert for the treatment of chronic non-infectious uveitis affecting the posterior segment of the eye)
- ASHR +2.2% (after Shanghai rises over 3% overnight)
- SNY +1% (confirms $11.85 mln settlement agreement to resolve allegations related to patient assistance)
Analyst comments:
- BEAM +2.5% (initiated with an Overweight at Barclays)
- CHGG +1.8% (upgraded to Strong Buy from Outperform at First Analysis Sec)
- AAPL +1.5% (upgraded to Outperform from Perform at Oppenheimer)
- GE +1.1% (upgraded to Neutral from Underweight at JP Morgan)
- SDGR +0.8% (initiated with an Outperform at BMO Capital Markets)